Avalon Globocare Corp (NAS:ALBT)
$ 0.2958 0.0245 (9.03%) Market Cap: 3.29 Mil Enterprise Value: 31.23 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 41/100

Avalon Globocare Corp at LD Micro Main Event Transcript

Oct 26, 2022 / 11:00PM GMT
Release Date Price: $4.91 (-6.45%)
Unidentified Participant

Good afternoon. Next up, we have Dr. David Jin from Avalon GlobalCare.

David Jin
Avalon GloboCare Corp. - President & CEO

Good afternoon, everyone. My name is David Jin, the President and CEO of Avalon GloboCare. I really appreciate the opportunity to present in this LD Micro Conference today. I will be making some forward-looking statements, so please refer to our regulatory filings and the risk factors that are associated.

As a medical oncologist, I have a genuine passion in curing cancer. You are probably familiar with some of the conventional cancer treatment options as in the left.

Over the last decade, there is a revolutionary approach called cellular immunotherapy, mostly about something called CAR-T therapy, which involves the isolation and genetic engineering of T cells, which are the major workhorses in our body. And you can imagine these CAR-T cells as a living drug equipped with a GPS-guided missile, directly targeting tumor cells and killing them. And this is a very impressive and revolutionary approach

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot